DE69231457D1 - Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate - Google Patents
Zyklodextrin-Zusammensetzung enthaltend Fumagillol-DerivateInfo
- Publication number
- DE69231457D1 DE69231457D1 DE69231457T DE69231457T DE69231457D1 DE 69231457 D1 DE69231457 D1 DE 69231457D1 DE 69231457 T DE69231457 T DE 69231457T DE 69231457 T DE69231457 T DE 69231457T DE 69231457 D1 DE69231457 D1 DE 69231457D1
- Authority
- DE
- Germany
- Prior art keywords
- composition containing
- cyclodextrin composition
- fumagillol derivatives
- water
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15050791 | 1991-06-21 | ||
JP23048991 | 1991-09-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231457D1 true DE69231457D1 (de) | 2000-10-26 |
DE69231457T2 DE69231457T2 (de) | 2001-05-23 |
Family
ID=26480076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231457T Expired - Fee Related DE69231457T2 (de) | 1991-06-21 | 1992-06-17 | Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate |
Country Status (5)
Country | Link |
---|---|
US (1) | US5486508A (de) |
EP (2) | EP1004318A3 (de) |
AT (1) | ATE196426T1 (de) |
CA (1) | CA2071623C (de) |
DE (1) | DE69231457T2 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0555693B1 (de) * | 1992-01-30 | 2001-09-05 | Takeda Chemical Industries, Ltd. | Verfahren zur Herstellung hoch-wasserlöslicher Zyklodextrinkomplexe |
US5602112A (en) * | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
US5840881A (en) * | 1992-11-27 | 1998-11-24 | Takeda Chemical Industries, Ltd. | Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility |
JPH06157330A (ja) * | 1992-11-27 | 1994-06-03 | Ensuiko Sugar Refining Co Ltd | タキソールのサイクロデキストリン包接物,その製造法と用途 |
US5684169A (en) * | 1992-11-27 | 1997-11-04 | Ensuiko Sugar Refining Co., Ltd. | Cyclodextrin inclusion complex of taxol, and method for its production and its use |
TW293036B (de) * | 1992-11-27 | 1996-12-11 | Takeda Pharm Industry Co Ltd | |
IL111184A (en) * | 1993-10-08 | 2000-08-13 | Farmarc Nederland B V Of Cito | Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin |
ZA949182B (en) * | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
ATE196427T1 (de) * | 1993-12-06 | 2000-10-15 | Takeda Chemical Industries Ltd | Zusammensetzung mit verbesserter wasserlöslichkeit, enthaltend eine wasserunlösliche oder an wasser schwerunlösliche verbindung |
FR2715307B1 (fr) * | 1994-01-25 | 1996-04-05 | Commissariat Energie Atomique | Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation. |
JPH10500982A (ja) * | 1994-05-27 | 1998-01-27 | ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ | 医薬組成物 |
ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
FR2741079B1 (fr) * | 1995-11-13 | 1997-12-26 | Oreal | Nouveaux composes, derives de cyclodextrine et leur utilisation, notamment en cosmetique |
HUP9600758A2 (en) * | 1996-03-27 | 1998-03-02 | Cyclolab Ciklodextrin Kutato F | Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption |
NL1003503C2 (nl) * | 1996-07-04 | 1998-01-07 | Negma Steba International Dev | Farmaceutische samenstelling voor orale toediening. |
US5942501A (en) * | 1996-08-16 | 1999-08-24 | Collaborative Laboratories, Inc. | Cyclodextrin derivative complex |
US6228997B1 (en) * | 1998-07-10 | 2001-05-08 | The United States Of America As Represented By The Secretary Of The Army | Transesterification of insoluble polysaccharides |
PE20020300A1 (es) * | 2000-08-22 | 2002-05-10 | Pharmacia Corp | Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco |
WO2002051381A1 (fr) * | 2000-12-26 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Substance poreuse et son procede de fabrication |
KR100451485B1 (ko) | 2002-03-28 | 2004-10-06 | 주식회사종근당 | 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물 |
CN1232539C (zh) * | 2002-05-10 | 2005-12-21 | 刘云清 | 有机药物与倍他环糊精衍生物的配合物及其制备方法 |
JP4732898B2 (ja) * | 2003-10-31 | 2011-07-27 | 株式会社カネカ | 還元型補酵素q含有組成物 |
PL1729813T3 (pl) * | 2004-04-01 | 2011-09-30 | Pf Medicament | Kompleksy inkluzyjne zawierające piroksykam, cyklodekstrynę i argininę |
US20060194762A1 (en) * | 2004-12-23 | 2006-08-31 | Olaf Reer | Composition comprising an epothilone and methods for producing a composition comprising an epothilone |
US20070082870A1 (en) * | 2005-10-11 | 2007-04-12 | Buchanan Charles M | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
JP5823093B2 (ja) | 2006-03-28 | 2015-11-25 | ジャヴェリン ファーマシューティカルズ インコーポレイテッド | 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物 |
CN101002782B (zh) * | 2007-01-10 | 2010-05-19 | 南京师范大学 | 含有头孢呋辛酯环糊精包合物的药物组合物及其制备方法 |
CN101264087B (zh) * | 2007-03-14 | 2010-10-27 | 南京师范大学 | 含有头孢泊肟酯环糊精包合物的药物组合物及其制备方法 |
CN102458114A (zh) | 2009-05-29 | 2012-05-16 | 锡德克斯药物公司 | 包含环糊精衍生物的可注射美法仑组合物及其制备和使用方法 |
US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
CN102349872B (zh) * | 2011-10-14 | 2013-05-22 | 南京威泰珐玛兽药研究所有限公司 | 一种硫酸头孢喹诺冻干粉针及其制备方法 |
CN102989003A (zh) * | 2012-10-30 | 2013-03-27 | 南通原亚精密机械有限公司 | 口服萘普生-环糊精包合物的制备方法 |
CN106236722A (zh) * | 2016-09-14 | 2016-12-21 | 佛山市弘泰药物研发有限公司 | 一种头孢替安酯分散片的制备方法 |
CN107080736A (zh) * | 2017-03-22 | 2017-08-22 | 山东信谊制药有限公司 | 一种劳拉西泮片的制备方法 |
CN112724200B (zh) * | 2019-10-28 | 2022-09-27 | 上海云泽生物科技有限公司 | 一种稳定环孢霉素a的稀释液及其应用 |
US20230364106A1 (en) * | 2020-09-21 | 2023-11-16 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
GB2630712A (en) * | 2022-01-25 | 2024-12-04 | Leiutis Pharmaceuticals Llp | Novel naproxen sodium preparations for parenteral |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835968A (ja) * | 1981-08-28 | 1983-03-02 | Hitachi Ltd | 半導体記憶装置 |
EP0094157B1 (de) * | 1982-04-30 | 1987-07-29 | Takeda Chemical Industries, Ltd. | Pharmazeutische Zusammensetzung und ihre Verwendung |
DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
JPS62281855A (ja) * | 1986-05-29 | 1987-12-07 | Daikin Ind Ltd | ビタミン,ビタミン誘導体,またはホルモンを含有する包接化合物 |
JPH0764884B2 (ja) * | 1986-11-27 | 1995-07-12 | 株式会社トクヤマ | シクロデキストリン組成物 |
JPH0714328B2 (ja) * | 1987-04-07 | 1995-02-22 | 昭和産業株式会社 | 麺類の製造方法 |
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
JP2806454B2 (ja) * | 1988-01-19 | 1998-09-30 | 武田薬品工業株式会社 | 脈管形成阻止剤 |
EP0335545B2 (de) * | 1988-03-29 | 1998-09-23 | University Of Florida | Pharmazeutische Zusammensetzungen für die parenterale Anwendung |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
US4954496A (en) * | 1988-08-12 | 1990-09-04 | Fujisawa Pharmaceutical Company, Ltd. | Cyclohexane derivatives and pharmaceutical compositions |
PH26256A (en) * | 1988-08-12 | 1992-04-01 | Fujisawa Pharmaceutical Co | Oxaspiro [2,5] octane derivative |
MY106598A (en) * | 1988-08-31 | 1995-06-30 | Australian Commercial Res & Development Ltd | Compositions and methods for drug delivery and chromatography. |
ATE106726T1 (de) * | 1988-09-01 | 1994-06-15 | Takeda Chemical Industries Ltd | Angiogenese hemmendes mittel. |
EP0682020A1 (de) * | 1988-09-01 | 1995-11-15 | Takeda Chemical Industries, Ltd. | Fumagillolderivate verwendbar als Angiogeneseinhibitoren |
IT1230566B (it) * | 1988-10-17 | 1991-10-28 | Vectorpharma Int | Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione |
IT1227626B (it) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
DE69001187T2 (de) * | 1989-03-06 | 1993-07-08 | Takeda Chemical Industries Ltd | 6-epifumagillole, ihre herstellung und ihre verwendung. |
ATE97410T1 (de) * | 1989-03-06 | 1993-12-15 | Takeda Chemical Industries Ltd | 6-amino-6-desoxyfumagillole, ihre herstellung und ihre verwendung. |
FR2647343B1 (fr) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
EP0415294A3 (en) * | 1989-08-31 | 1991-06-12 | Takeda Chemical Industries, Ltd. | Cyclohexanol derivatives, production and use thereof |
TW282399B (de) * | 1990-05-25 | 1996-08-01 | Takeda Pharm Industry Co Ltd |
-
1992
- 1992-06-17 AT AT92110230T patent/ATE196426T1/de not_active IP Right Cessation
- 1992-06-17 EP EP00104213A patent/EP1004318A3/de not_active Withdrawn
- 1992-06-17 EP EP92110230A patent/EP0519428B1/de not_active Expired - Lifetime
- 1992-06-17 DE DE69231457T patent/DE69231457T2/de not_active Expired - Fee Related
- 1992-06-18 CA CA002071623A patent/CA2071623C/en not_active Expired - Fee Related
-
1994
- 1994-04-28 US US08/236,699 patent/US5486508A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0519428A3 (en) | 1993-05-05 |
US5486508A (en) | 1996-01-23 |
CA2071623A1 (en) | 1992-12-22 |
EP0519428B1 (de) | 2000-09-20 |
EP1004318A2 (de) | 2000-05-31 |
DE69231457T2 (de) | 2001-05-23 |
ATE196426T1 (de) | 2000-10-15 |
EP1004318A3 (de) | 2002-08-07 |
EP0519428A2 (de) | 1992-12-23 |
CA2071623C (en) | 2003-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE196426T1 (de) | Zyklodextrin-zusammensetzung enthaltend fumagillol-derivate | |
MX9203960A (es) | Nuevas composiciones farmaceuticas a base de un derivado de taxano. | |
NO860971L (no) | Nye derivater av gamma-cyklodextrin. | |
PT972762E (pt) | Novos analogos estruturais da vitamina d | |
NL193024B (nl) | Piperazinederivaten en farmaceutisch preparaat dat een dergelijk piperazinederivaat bevat. | |
DE68901043D1 (de) | Waessriges pharmazeutisches praeparat. | |
DE69214704D1 (de) | Stabilisiertes Vitamin D Arzneimittel | |
NO891415D0 (no) | Fremstilling av substituerte flavonoidforbindelser og salter og farmasoeytiske preparater derav. | |
FI935728A0 (fi) | Substituerade 4-fenylpyridoner och 4-fenyl-2-alkoxipyridiner | |
KR960702730A (ko) | 벤즈이소티아졸린-3-온 및 크산테인 고무의 안정한 수성 조제물(stable aqueous formulation of benzisothiazolin-3-one and xanthan gum) | |
NL192832B (nl) | 1,8 gebrugde 6-halogeen-4-chinolon-3-carbonzuurderivaten en farmaceutisch preparaat dat een dergelijk derivaat bevat. | |
DE69107547D1 (de) | Persäure-Clathrate, ihre Herstellung und ihre Verwendungen. | |
BR9107294A (pt) | Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante | |
NO923721D0 (no) | 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav | |
NL194827B (nl) | Thieno-triazolo-diazepinederivaten en farmaceutische preparaten die een dergelijk derivaat bevatten. | |
DK1211250T3 (da) | C10-Taxanderivater samt farmaceutiske præparater | |
DK0400637T3 (da) | Præparat indeholdende FR115224-substans til parenteral administration | |
DK235089A (da) | Anvendelse af aetiprotimodae til fremstilling af et laegemiddel imod virusinfektioner | |
ES2062125T3 (es) | Una composicion farmaceutica que contiene derivados de hidantoina. | |
DK251289D0 (da) | Avermectinderivater | |
FR2676364B1 (fr) | Composition pharmaceutique a base de derives d'aminobutanone. | |
ATE276238T1 (de) | C7-taxan-derivate und diese enthaltende pharmazeutische zusammenstellungen | |
NO895078D0 (no) | Lavmolekularvektsderivater av prourokinase, samt farmasoeytiske blandinger derav. | |
DK0424886T3 (da) | Markerings- og denatureringsmiddel for vandopløselige organiske opløsningsmidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |